HK1137352A1 - Therapeutic use of at least one botulic neurotoxin in the treatment of pain induced by at least one antineoplastic agent - Google Patents
Therapeutic use of at least one botulic neurotoxin in the treatment of pain induced by at least one antineoplastic agentInfo
- Publication number
- HK1137352A1 HK1137352A1 HK10101268.1A HK10101268A HK1137352A1 HK 1137352 A1 HK1137352 A1 HK 1137352A1 HK 10101268 A HK10101268 A HK 10101268A HK 1137352 A1 HK1137352 A1 HK 1137352A1
- Authority
- HK
- Hong Kong
- Prior art keywords
- treatment
- therapeutic use
- antineoplastic agent
- pain induced
- botulic neurotoxin
- Prior art date
Links
Classifications
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K38/00—Medicinal preparations containing peptides
- A61K38/16—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
- A61K38/43—Enzymes; Proenzymes; Derivatives thereof
- A61K38/46—Hydrolases (3)
- A61K38/48—Hydrolases (3) acting on peptide bonds (3.4)
- A61K38/4886—Metalloendopeptidases (3.4.24), e.g. collagenase
- A61K38/4893—Botulinum neurotoxin (3.4.24.69)
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P25/00—Drugs for disorders of the nervous system
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P25/00—Drugs for disorders of the nervous system
- A61P25/02—Drugs for disorders of the nervous system for peripheral neuropathies
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P25/00—Drugs for disorders of the nervous system
- A61P25/04—Centrally acting analgesics, e.g. opioids
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P29/00—Non-central analgesic, antipyretic or antiinflammatory agents, e.g. antirheumatic agents; Non-steroidal antiinflammatory drugs [NSAID]
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P35/00—Antineoplastic agents
Landscapes
- Health & Medical Sciences (AREA)
- Life Sciences & Earth Sciences (AREA)
- Animal Behavior & Ethology (AREA)
- Chemical & Material Sciences (AREA)
- Veterinary Medicine (AREA)
- Public Health (AREA)
- Medicinal Chemistry (AREA)
- General Health & Medical Sciences (AREA)
- Pharmacology & Pharmacy (AREA)
- Organic Chemistry (AREA)
- General Chemical & Material Sciences (AREA)
- Chemical Kinetics & Catalysis (AREA)
- Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
- Engineering & Computer Science (AREA)
- Bioinformatics & Cheminformatics (AREA)
- Neurology (AREA)
- Neurosurgery (AREA)
- Biomedical Technology (AREA)
- Proteomics, Peptides & Aminoacids (AREA)
- Gastroenterology & Hepatology (AREA)
- Immunology (AREA)
- Pain & Pain Management (AREA)
- Epidemiology (AREA)
- Rheumatology (AREA)
- Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
- Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
- Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
Applications Claiming Priority (2)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
FR0609435A FR2907680B1 (fr) | 2006-10-27 | 2006-10-27 | Utilisation therapeutique d'au moins une neurotoxine botulique dans le traitement de la douleur induite par au moins un agent anti-cancereux |
PCT/FR2007/001773 WO2008059126A1 (fr) | 2006-10-27 | 2007-10-26 | Utilisation therapeutique d'au moins une neurotoxine botulique dans le traitement de la douleur induite par au moins un agent anti-cancereux |
Publications (1)
Publication Number | Publication Date |
---|---|
HK1137352A1 true HK1137352A1 (en) | 2010-07-30 |
Family
ID=38109619
Family Applications (1)
Application Number | Title | Priority Date | Filing Date |
---|---|---|---|
HK10101268.1A HK1137352A1 (en) | 2006-10-27 | 2010-02-04 | Therapeutic use of at least one botulic neurotoxin in the treatment of pain induced by at least one antineoplastic agent |
Country Status (13)
Country | Link |
---|---|
US (1) | US8273359B2 (xx) |
EP (1) | EP2083837B1 (xx) |
JP (1) | JP5386359B2 (xx) |
CN (1) | CN101541336B (xx) |
CA (1) | CA2667128C (xx) |
DK (1) | DK2083837T3 (xx) |
ES (1) | ES2532850T3 (xx) |
FR (1) | FR2907680B1 (xx) |
HK (1) | HK1137352A1 (xx) |
PL (1) | PL2083837T3 (xx) |
PT (1) | PT2083837E (xx) |
RU (1) | RU2483747C2 (xx) |
WO (1) | WO2008059126A1 (xx) |
Families Citing this family (16)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
US7780967B2 (en) * | 2000-02-08 | 2010-08-24 | Allergan, Inc. | Reduced toxicity Clostridial toxin pharmaceutical compositions |
US9211248B2 (en) | 2004-03-03 | 2015-12-15 | Revance Therapeutics, Inc. | Compositions and methods for topical application and transdermal delivery of botulinum toxins |
FR2889936B1 (fr) * | 2005-09-01 | 2007-12-21 | Sod Conseils Rech Applic | Methode pour quantifier une neurotoxine cholinergique dans un echantillon |
FR2902341B1 (fr) * | 2006-06-16 | 2011-02-25 | Scras | Utilisation therapeutique simultanee, separee ou etalee dans le temps d'au moins une neurotoxine botulique, et d'au moins un derive opiace |
ES2537579T3 (es) * | 2006-10-27 | 2015-06-09 | The Chemo-Sero-Therapeutic Research Institute | Preparación que contiene toxina botulínica de tipo A muy purificada derivada de patógeno de botulismo del lactante |
FR2907680B1 (fr) * | 2006-10-27 | 2012-12-28 | Scras | Utilisation therapeutique d'au moins une neurotoxine botulique dans le traitement de la douleur induite par au moins un agent anti-cancereux |
FR2910327B1 (fr) * | 2006-12-22 | 2013-04-26 | Scras | Utilisation d'au moins une neurotoxine botulique pour traiter la douleur induite par les traitements therapeutiques du virus du sida. |
FR2930447B1 (fr) | 2008-04-25 | 2010-07-30 | Sod Conseils Rech Applic | Utilisation therapeutique d'au moins une neurotoxine botulique dans le traitement de la douleur dans le cas de la neuropathie diabetique |
US20100332337A1 (en) * | 2009-06-25 | 2010-12-30 | Bullock Roddy Mckee | Universal one-click online payment method and system |
HUE053147T2 (hu) | 2012-05-30 | 2021-06-28 | Harvard College | Módosított botulinum neurotoxin |
EP2952205B1 (en) * | 2014-06-06 | 2017-08-09 | Kleiner-Fisman, Galit | Botulinum toxin for use in the treatment of paratonia |
HUE057258T2 (hu) * | 2015-03-26 | 2022-05-28 | Harvard College | Szerkesztett Botulinum neurotoxin |
US10414953B2 (en) | 2016-02-19 | 2019-09-17 | Avery Dennison Corporation | Two stage methods for processing adhesives and related compositions |
CN110072880A (zh) | 2016-08-24 | 2019-07-30 | 哈佛大学校长及研究员协会 | 工程化肉毒杆菌神经毒素 |
US10640595B2 (en) | 2016-10-25 | 2020-05-05 | Avery Dennison Corporation | Controlled architecture polymerization with photoinitiator groups in backbone |
US20230165812A1 (en) * | 2020-02-27 | 2023-06-01 | President And Fellows Of Harvard College | Nociceptor neurons control cancer immunosurveillance |
Family Cites Families (28)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
EP1563843B1 (en) * | 1993-12-28 | 2013-08-07 | Allergan, Inc. | Botulinum toxins for treating muscle disorders |
DE19501266A1 (de) * | 1995-01-18 | 1996-07-25 | Madaus Ag | Verfahren zur Herstellung von Flavano-Lignan-Zubereitungen mit verbesserter Freisetzung und Resorbierbarkeit danach erhältliche Zubereitungen und deren Verwendung zur Herstellung von Arzneimitteln |
SE9803239D0 (sv) * | 1998-09-24 | 1998-09-24 | Diabact Ab | Composition for the treatment of acute pain |
US6113915A (en) * | 1999-10-12 | 2000-09-05 | Allergan Sales, Inc. | Methods for treating pain |
US6139845A (en) * | 1999-12-07 | 2000-10-31 | Allergan Sales, Inc. | Method for treating cancer with a neurotoxin |
US20060269575A1 (en) * | 2000-02-08 | 2006-11-30 | Allergan, Inc. | Botulinum toxin pharmaceutical compositions formulated with recombinant albumin |
US7780967B2 (en) * | 2000-02-08 | 2010-08-24 | Allergan, Inc. | Reduced toxicity Clostridial toxin pharmaceutical compositions |
DK1253932T3 (da) | 2000-02-08 | 2005-06-27 | Allergan Inc | Lægemidler med botulinustoxin |
US6464986B1 (en) * | 2000-04-14 | 2002-10-15 | Allegan Sales, Inc. | Method for treating pain by peripheral administration of a neurotoxin |
US20020192239A1 (en) * | 2001-01-09 | 2002-12-19 | Borodic Gary E. | Use of botulinum toxin for the treatment of chronic facial pain |
KR20030018827A (ko) | 2001-08-31 | 2003-03-06 | 서구일 | A형 보툴리눔 독소를 유효성분으로 포함하는 신경차단제,및 이를 이용한 교감신경절 차단의 적응질환 치료제 |
CA2369810C (en) * | 2002-01-30 | 2007-08-07 | 1474791 Ontario Limited | Method of treating pain |
US20040009180A1 (en) | 2002-07-11 | 2004-01-15 | Allergan, Inc. | Transdermal botulinum toxin compositions |
US20050152905A1 (en) * | 2002-08-22 | 2005-07-14 | Omoigui Osemwota S. | Method of biochemical treatment of persistent pain |
US20060178354A1 (en) * | 2003-02-27 | 2006-08-10 | Lucas John M | Methods and compositions for the treatment of chronic pain using dhea and derivatives thereof |
US20040247623A1 (en) * | 2003-03-24 | 2004-12-09 | Roger Cady | Method and article for treatment of sensory neuron related disorders through transdermal application of botulinum toxin |
US7270287B2 (en) * | 2004-01-06 | 2007-09-18 | Allergan, Inc. | Botulinum toxin treatment for kinesia |
GB2417419A (en) | 2004-07-12 | 2006-03-01 | Ipsen Ltd | Therapeutic use of Botulinum toxin |
GB2419526A (en) | 2004-10-28 | 2006-05-03 | Ipsen Ltd | Pharmaceutical composition containing botulinum neurotoxin |
GB2416692A (en) | 2004-08-04 | 2006-02-08 | Ipsen Ltd | Pharmaceutical composition containing botulinum neurotoxin |
US20060240043A1 (en) * | 2004-10-08 | 2006-10-26 | Meyerson Laurence R | Methods and compositions for treating migraine pain |
WO2006094539A1 (en) * | 2005-03-03 | 2006-09-14 | Université Catholique de Louvain | Methods and compositions for the treatment of cancer |
WO2006122123A2 (en) * | 2005-05-09 | 2006-11-16 | Levin Bruce H | Methods of alleviating disorders and their associated pain |
KR100726441B1 (ko) * | 2005-11-22 | 2007-06-11 | 삼성전자주식회사 | 현상장치 및 이를 이용한 화상형성장치 |
FR2902341B1 (fr) | 2006-06-16 | 2011-02-25 | Scras | Utilisation therapeutique simultanee, separee ou etalee dans le temps d'au moins une neurotoxine botulique, et d'au moins un derive opiace |
FR2907680B1 (fr) * | 2006-10-27 | 2012-12-28 | Scras | Utilisation therapeutique d'au moins une neurotoxine botulique dans le traitement de la douleur induite par au moins un agent anti-cancereux |
FR2910327B1 (fr) * | 2006-12-22 | 2013-04-26 | Scras | Utilisation d'au moins une neurotoxine botulique pour traiter la douleur induite par les traitements therapeutiques du virus du sida. |
FR2930447B1 (fr) * | 2008-04-25 | 2010-07-30 | Sod Conseils Rech Applic | Utilisation therapeutique d'au moins une neurotoxine botulique dans le traitement de la douleur dans le cas de la neuropathie diabetique |
-
2006
- 2006-10-27 FR FR0609435A patent/FR2907680B1/fr not_active Expired - Fee Related
-
2007
- 2007-10-26 CN CN2007800399471A patent/CN101541336B/zh not_active Expired - Fee Related
- 2007-10-26 PT PT07866446T patent/PT2083837E/pt unknown
- 2007-10-26 ES ES07866446.3T patent/ES2532850T3/es active Active
- 2007-10-26 RU RU2009120021/15A patent/RU2483747C2/ru active
- 2007-10-26 PL PL07866446T patent/PL2083837T3/pl unknown
- 2007-10-26 DK DK07866446.3T patent/DK2083837T3/en active
- 2007-10-26 JP JP2009533902A patent/JP5386359B2/ja not_active Expired - Fee Related
- 2007-10-26 EP EP07866446.3A patent/EP2083837B1/fr active Active
- 2007-10-26 CA CA2667128A patent/CA2667128C/fr not_active Expired - Fee Related
- 2007-10-26 US US12/447,443 patent/US8273359B2/en active Active
- 2007-10-26 WO PCT/FR2007/001773 patent/WO2008059126A1/fr active Application Filing
-
2010
- 2010-02-04 HK HK10101268.1A patent/HK1137352A1/xx not_active IP Right Cessation
Also Published As
Publication number | Publication date |
---|---|
PL2083837T3 (pl) | 2015-06-30 |
ES2532850T3 (es) | 2015-04-01 |
US8273359B2 (en) | 2012-09-25 |
CN101541336B (zh) | 2012-12-19 |
DK2083837T3 (en) | 2015-03-23 |
CA2667128A1 (fr) | 2008-05-22 |
EP2083837B1 (fr) | 2015-01-07 |
FR2907680A1 (fr) | 2008-05-02 |
EP2083837A1 (fr) | 2009-08-05 |
JP2010507635A (ja) | 2010-03-11 |
CN101541336A (zh) | 2009-09-23 |
WO2008059126A1 (fr) | 2008-05-22 |
FR2907680B1 (fr) | 2012-12-28 |
CA2667128C (fr) | 2017-08-29 |
JP5386359B2 (ja) | 2014-01-15 |
US20100068231A1 (en) | 2010-03-18 |
RU2009120021A (ru) | 2010-12-10 |
PT2083837E (pt) | 2015-03-26 |
RU2483747C2 (ru) | 2013-06-10 |
Similar Documents
Publication | Publication Date | Title |
---|---|---|
HK1137352A1 (en) | Therapeutic use of at least one botulic neurotoxin in the treatment of pain induced by at least one antineoplastic agent | |
GB0602178D0 (en) | Therapeutic treatment | |
EP1985302A4 (en) | DRUGS FOR TUMOR THERAPY AND ITS USE | |
IL185462A0 (en) | New pharmaceutical compositions useful in the treatment of pain | |
GB0625659D0 (en) | Therapeutic compounds and their use | |
IL186616A (en) | Spyro-oxa-indoles and their use as drugs | |
SI1978947T1 (sl) | Nitrooksiderivati za uporabo pri zdravljenju mišičnih distrofij | |
IL201422A0 (en) | Therapeutic agents useful for treating pain | |
PT2101731T (pt) | Endoxifeno para utilização no tratamento de cancro | |
HK1129844A1 (en) | Use of l-cytosine nucleoside analogs in the manufacture of a medicament for use in treating cancer and other conditions or disease states l- | |
GB0608655D0 (en) | Therapeutic Treatment | |
EP2219448A4 (en) | THERAPEUTIC COMPOUNDS AND THEIR USE IN THE TREATMENT OF DISEASES AND SUFFERINGS | |
HK1209053A1 (zh) | 地來西坦在慢性疼痛的治療中的用途 | |
PL2148667T3 (pl) | Stosowanie pochodnych cycloheksanoheksolu w leczeniu chorób oczu | |
GB0610909D0 (en) | Therapeutic treatment | |
IL201426A0 (en) | Drug combination and its use in the treatment of muscle loss | |
ZA200810199B (en) | Rinse-off therapeutic agents for treating skin | |
ZA200709542B (en) | Combination therapy in the treatment of cancer | |
IL192933A0 (en) | Benzoisoindole derivatives for the treatment of pain | |
EP2005964A4 (en) | MEDICAMENT FOR TREATING HYPERPHOSPHATEEMIA AND PREPARATION METHOD THEREOF | |
GB0710277D0 (en) | Use of antivirals in the treatment of medical disorders | |
EP1908467A4 (en) | HERPESVIRUS DERIVED THERAPEUTIC AGENTS AGAINST PAIN | |
GB0425633D0 (en) | Topical formulations for use in the treatment or prevention of dermatological conditions | |
EP1900363A4 (en) | THERAPEUTIC AGENT AGAINST PAIN | |
GB0509911D0 (en) | Medical treatment aid for use in treating children |
Legal Events
Date | Code | Title | Description |
---|---|---|---|
PC | Patent ceased (i.e. patent has lapsed due to the failure to pay the renewal fee) |
Effective date: 20211026 |